Signed license agreements attracted a few speculators to shares of a tech junior Tuesday. Here’s some small stocks making big moves on Tuesday, February 6, 2018 (as of 4 pm EST):
3tl Technologies Corp. (TSXV:TTM) shares jumped as much as 17% before ending 4% higher at $0.15 on Tuesday after the tech junior announced that it has signed seven license agreements in the last part of 2017, resulting in revenue growth of nearly 80%. Approximately 60% of the revenues from the seven license agreements will be recognized in 2018.
As well, shares of Element Fleet Management Corp. (TSX:EFN) sank 29% to $5.67 as the fleet management company said it expects 2018 core fleet adjusted operating income will be down approximately 3% to 5% on a currency neutral basis due to “integration challenges.”
HIT Technologies Inc. (TSXV:HIT), meanwhile, reported that it has launched the completely redesigned collection of Hitcase TrueLUX Optics, including the TrueLUX SuperWide, Wide, and Macro. HIT Technologies stock moved up 27% to $0.07 following the announcement.
Finally, Vaxil Bio Ltd. (TSXV:VXL) shares rose 27% to $0.14 after the cancer immunotherapy company announced that Ari Kellen has acquired 4,985,000 units of Vaxil Bio at $0.10 per unit, by way of a private placement. As a result of this transaction, Mr. Kellen now owns approximately 5.74% of Vaxil’s issued and outstanding common shares on a non-diluted basis.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
